Beyond Air Appoints Dan Moorhead as Chief Financial Officer

Generated by AI AgentNyra FeldonReviewed byAInvest News Editorial Team
Monday, Jan 5, 2026 4:12 am ET2min read
Aime RobotAime Summary

-

appoints Dan Moorhead as CFO effective January 5, 2026, succeeding interim CFO Duke Dewrell who returns to Controller role.

- Moorhead brings 20+ years of finance leadership, including 8 years as Zynex CFO, and received a 70,000-share stock option with 4-year vesting.

- The appointment aims to strengthen financial stewardship during Beyond Air's growth phase, with analysts monitoring strategic execution and market response.

- Moorhead's stock award aligns with Nasdaq rules and reflects the company's focus on retaining talent to advance its nitric oxide-based medical device pipeline.

Beyond Air, Inc. (NASDAQ: XAIR) announced the appointment of Dan Moorhead as Chief Financial Officer, effective January 5, 2026. This move follows Duke Dewrell's interim role as CFO since November 2025, with

.

Moorhead brings over 20 years of finance leadership experience across public and private companies. He most recently served as CFO of Zynex, Inc. from June 2017 to August 2025, where

.

In connection with his appointment, the Company granted an inducement stock option award to Mr. Moorhead upon entering into employment. The inducement option is exercisable for the purchase of 70,000 shares of the Company's common stock, with a ten-year term and

.

Moorhead expressed his excitement about joining

at a pivotal moment in the Company's evolution. He emphasized his commitment to supporting the successful execution of the company's commercial strategy and .

The company is a commercial-stage medical device and biopharmaceutical company focused on

to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors.

Beyond Air's LungFit PH system has received FDA approval and CE Mark for treating term and near-term neonates with hypoxic respiratory failure. The company is also advancing other LungFit systems in clinical trials for treating severe lung infections and chronic, refractory lung infections.

Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, highlighted Moorhead's strong track record of guiding companies through significant growth. He expressed confidence in

and build a market-leading company.

Moorhead is a CPA and holds a B.B.A. in Accounting from the University of Northern Colorado.

was approved by the independent compensation committee of the Board in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).

Why Did This Appointment Occur?

Beyond Air's decision to appoint Dan Moorhead follows a period of interim leadership under Duke Dewrell. The company

to support its strategic growth and financial stewardship.

Moorhead's background in guiding companies through significant growth aligns with Beyond Air's current strategic objectives.

, Inc. provides a strong foundation for his new role.

The stock option award granted to Moorhead is designed to

and align his interests with those of the company's shareholders.

What Does the Appointment Mean for Beyond Air?

Moorhead's appointment is expected to support the company's focus on expanding its commercial operations and advancing its product pipeline.

and ensuring strong financial stewardship.

The company highlighted the importance of having a CFO with experience in guiding companies through significant growth.

in this regard.

The stock option award is part of a broader strategy to attract and retain top talent. The vesting schedule ensures that Moorhead's compensation is tied to long-term performance.

What Are Analysts Watching Next?

Analysts will be watching how the new leadership team executes on Beyond Air's strategic objectives.

and expanding its commercial operations is a key area of interest.

The market response to Moorhead's appointment will also be closely monitored. Investors are likely to

and stock price appreciation.

The company's ability to navigate regulatory and competitive challenges will also be a key focus for analysts.

is expected to drive long-term value for shareholders.

Comments



Add a public comment...
No comments

No comments yet